Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination

NEUROPHARMACOLOGY · Published 2026-05-27 · DOI 10.1016/j.neuropharm.2026.111042

Authors (4)

Mohamed N. Fawzy, Ahmed M. Abdelaziz, Mustafa M. Shokr, Mohamed K. Fathy

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Fawzy, M., Abdelaziz, A., Shokr, M., et al. (2026). Targeting the microbiome-NLRP3-ferroptosis axis in multiple sclerosis: Neuropharmacological implications for microglial dysfunction and demyelination. NEUROPHARMACOLOGY. https://doi.org/10.1016/j.neuropharm.2026.111042

Related articles